
Karuna, Naurex Alumni Launch New Biotech to Modulate Synaptic Plasticity for Neuro Diseases
Founders and executives of Karuna Therapeutics and Naurex are back with a brand-new biotech, aiming to “build the first synapse-targeted company” for the treatment of diseases like depression and Alzheimer’s, according to CEO Derek Small, former chief …